Pacific Biosciences of California, Inc.
PACB
$1.13
$0.043.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.37M | -60.73M | -173.32M | -78.18M | -82.02M |
| Total Depreciation and Amortization | 10.95M | 16.10M | 14.29M | 12.01M | 11.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.34M | 16.43M | 111.10M | 15.83M | 20.50M |
| Change in Net Operating Assets | 8.37M | -17.27M | -6.33M | -25.35M | -7.74M |
| Cash from Operations | -30.65M | -45.46M | -54.26M | -75.68M | -57.56M |
| Capital Expenditure | -1.62M | 787.00K | -1.48M | -3.88M | -2.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.86M | 22.28M | 78.32M | -30.26M | -64.55M |
| Cash from Investing | 58.24M | 23.07M | 76.84M | -34.14M | -66.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.20M | 0.00 | -152.00K | -338.00K | -445.00K |
| Issuance of Common Stock | 0.00 | 812.00K | 0.00 | 6.89M | 936.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.20M | -- | -- | -- | -82.09M |
| Cash from Financing | -50.20M | 812.00K | -152.00K | 6.55M | -81.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.61M | -21.59M | 22.42M | -103.27M | -205.74M |